CClinicalTrials.gg
CompletedNCT04106063KID SSQ12Updated Dec 17, 2021

A New Speech, Spatial, and Qualities of Hearing Scale Short-Form for Deaf Children

An observational study in Deafness and Pediatric, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 7 Years to 17 Years. Per ClinicalTrials.gov, last updated 2021-12-17.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
154
Ages
7 Years to 17 Years
Sex
All
01

Study summary

Deafness significantly affects several auditory tasks of everyday life in children: understanding speech in quiet and noisy environments, spatial location of sounds ...

These difficulties in locating sound sources are often ignored by parents and underestimated by children. Nowadays we there is specific tools to evaluate these problems in children. Indeed, there is a validated French questionnaire (Speech and Spatial Questionnaire SSQ) for adults that evaluates auditory abilities, including sound localization, in different tasks of daily life. Although robust, this questionnaire includes 49 questions and is too long for daily use in consultation. For this reason, Moulin et al validated in 2018 a short version of the SSQ questionnaire for adults with only 15 items.

Based on this model, the aim of this study is to develop and test a paediatric questionnaire with 12 items to assess more specifically auditory difficulties in deaf children. This questionnaire will follow the validated frame of the adult SSQ questionnaire and will consist of three subscales: speech hearing (4 items), spatial hearing (4 items), and qualities of hearing (4 items). These 3 subscales are identical to those defined in long and short form pf the adult SSQ questionnaire.

02

Conditions studied

  • Deafness
  • Pediatric

Browse trials for

03

In context

Deafness

609 studies on the registry are indexed under Deafness; 111 are open to participants now.

This study's enrollment of 154 is above the median of 80 across 168 observational studies indexed under Deafness.

Browse Deafness studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,826 studies on the registry; 439 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

All Children between 7 and 17 years old attending medical appointment for temporary or persistent deafness in our ENT department

Inclusion criteria

  • Male or female aged 7-17 (inclusive)
  • Attending medical appointment for temporary or persistent deafness
  • Able to understand the experimental instructions

Exclusion criteria

Exclusion Criteria:

none-

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
154 participants (actual)
Patient registry
No

Groups and cohorts

  • deaf children

    All Children between 7 and 17 years old attending medical appointment for temporary or persistent deafness in our Ear, Nose and Throat (ENT) department

    Other: KID SSQ12 questionnaire

Interventions

  • OtherKID SSQ12 questionnaire

    During a face to face interview (maximum 15 minutes), the child will complete a short questionnaire (KID SSQ12 questionnaire) to assess his auditory difficulties

06

What researchers measure

Primary outcomes

  1. KID SSQ12 questionnaire score

    This questionnaire evaluates auditive abilities (including sound localisation) in different every day life tasks, in deaf children. It is made up of 12 items ; for each item the score range is between 0 (worse outcome) and 10 (best outcome). The questionnaire is devided into 3 subscores of 4 items : speech audition, spatial audition and quality of audition. Thanks to that tool, internal structures (internal consistency, sub-scale structure obtained by principal component analysis and cluster analysis) and psychometric values will be compared with adult versions of the questionnaire (complete and abbreviated) published in the international literature. Overall scores, scores by subscales and items will be compared.

    Time frame: At inclusion

07

Study locations

1 site
  • ENT departement, Edouard Herriot Hospital
    Lyon, 69003, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 17, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04106063
Lead sponsor
Hospices Civils de Lyon
Responsible party
Sponsor
First posted
Sep 26, 2019
Start date
Nov 20, 2019
Primary completion
Nov 23, 2020
Completion
Nov 23, 2020
Last update
Dec 17, 2021

Study contacts

Eric TRUY, MD, PhD
principal investigator · Hospices Civils de Lyon

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion